| Dr Wendy L Bauer, MD | |
|
2854 S 11th St, Kalamazoo, MI 49009-2129 | |
| (269) 345-6197 | |
| (269) 345-9734 |
| Full Name | Dr Wendy L Bauer |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 35 Years |
| Location | 2854 S 11th St, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164417416 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | WB061276 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Methodist Hospital | 0244148633 | 598 |
News Archive
Men who are married or in common-law relationships seek medical care sooner for heart attacks compared with single, divorced or widowed men, found a new study in CMAJ.
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed.
New research conducted at the University of Alabama at Birmingham has shown that a particular type of diet could help women with ovarian cancer to lose weight and improve their quality of life and cancer-related measures.
› Verified 1 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
Men who are married or in common-law relationships seek medical care sooner for heart attacks compared with single, divorced or widowed men, found a new study in CMAJ.
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed.
New research conducted at the University of Alabama at Birmingham has shown that a particular type of diet could help women with ovarian cancer to lose weight and improve their quality of life and cancer-related measures.
› Verified 1 days ago
| Entity Name | Obgyn Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609967157 PECOS PAC ID: 4284727249 Enrollment ID: O20070906000646 |
News Archive
Men who are married or in common-law relationships seek medical care sooner for heart attacks compared with single, divorced or widowed men, found a new study in CMAJ.
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed.
New research conducted at the University of Alabama at Birmingham has shown that a particular type of diet could help women with ovarian cancer to lose weight and improve their quality of life and cancer-related measures.
› Verified 1 days ago
| Entity Name | Bronson Lakeview Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1962508259 PECOS PAC ID: 9032008495 Enrollment ID: O20080516000276 |
News Archive
Men who are married or in common-law relationships seek medical care sooner for heart attacks compared with single, divorced or widowed men, found a new study in CMAJ.
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed.
New research conducted at the University of Alabama at Birmingham has shown that a particular type of diet could help women with ovarian cancer to lose weight and improve their quality of life and cancer-related measures.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wendy L Bauer, MD 2854 S 11th St, Kalamazoo, MI 49009-2129 Ph: (269) 345-6197 | Dr Wendy L Bauer, MD 2854 S 11th St, Kalamazoo, MI 49009-2129 Ph: (269) 345-6197 |
News Archive
Men who are married or in common-law relationships seek medical care sooner for heart attacks compared with single, divorced or widowed men, found a new study in CMAJ.
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed.
New research conducted at the University of Alabama at Birmingham has shown that a particular type of diet could help women with ovarian cancer to lose weight and improve their quality of life and cancer-related measures.
› Verified 1 days ago
Dr. Amanda Keating Walker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Paul I Berkowitz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John Street, Box 42, Kalamazoo, MI 49007 Phone: 269-341-6417 Fax: 269-341-8743 | |
Malcolm Hamilton, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Dr. Benjamin Baines Mize, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 N Park St, Kalamazoo, MI 49007 Phone: 269-382-2500 Fax: 269-384-8617 | |
Jordan Wroblewski, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-6000 | |
Brandi L Boone, CNM Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 |